IBDEI0ET ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37065,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,37065,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,37065,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,37066,0)
 ;;=D09.0^^107^1487^44
 ;;^UTILITY(U,$J,358.3,37066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37066,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,37066,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,37066,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,37067,0)
 ;;=D06.9^^107^1487^45
 ;;^UTILITY(U,$J,358.3,37067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37067,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,37067,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,37067,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,37068,0)
 ;;=D06.0^^107^1487^47
 ;;^UTILITY(U,$J,358.3,37068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37068,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,37068,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,37068,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,37069,0)
 ;;=D06.1^^107^1487^48
 ;;^UTILITY(U,$J,358.3,37069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37069,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,37069,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,37069,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,37070,0)
 ;;=D06.7^^107^1487^46
 ;;^UTILITY(U,$J,358.3,37070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37070,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,37070,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,37070,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,37071,0)
 ;;=D04.9^^107^1487^49
 ;;^UTILITY(U,$J,358.3,37071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37071,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,37071,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,37071,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,37072,0)
 ;;=C91.11^^107^1487^52
 ;;^UTILITY(U,$J,358.3,37072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37072,1,3,0)
 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,In Remission
 ;;^UTILITY(U,$J,358.3,37072,1,4,0)
 ;;=4^C91.11
 ;;^UTILITY(U,$J,358.3,37072,2)
 ;;=^5001766
 ;;^UTILITY(U,$J,358.3,37073,0)
 ;;=C91.10^^107^1487^53
 ;;^UTILITY(U,$J,358.3,37073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37073,1,3,0)
 ;;=3^Chronic Lymphocytic Leukemia of B-Cell Type,Not in Remission
 ;;^UTILITY(U,$J,358.3,37073,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,37073,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,37074,0)
 ;;=C92.11^^107^1487^54
 ;;^UTILITY(U,$J,358.3,37074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37074,1,3,0)
 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,In Remission
 ;;^UTILITY(U,$J,358.3,37074,1,4,0)
 ;;=4^C92.11
 ;;^UTILITY(U,$J,358.3,37074,2)
 ;;=^5001793
 ;;^UTILITY(U,$J,358.3,37075,0)
 ;;=C92.10^^107^1487^55
 ;;^UTILITY(U,$J,358.3,37075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37075,1,3,0)
 ;;=3^Chronic Myeloid Leukemia,BCR/ABL-Positive,Not in Remission
 ;;^UTILITY(U,$J,358.3,37075,1,4,0)
 ;;=4^C92.10
 ;;^UTILITY(U,$J,358.3,37075,2)
 ;;=^5001792
 ;;^UTILITY(U,$J,358.3,37076,0)
 ;;=D47.1^^107^1487^56
 ;;^UTILITY(U,$J,358.3,37076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37076,1,3,0)
 ;;=3^Chronic Myeloproliferative Disease
 ;;^UTILITY(U,$J,358.3,37076,1,4,0)
 ;;=4^D47.1
 ;;^UTILITY(U,$J,358.3,37076,2)
 ;;=^5002256
 ;;^UTILITY(U,$J,358.3,37077,0)
 ;;=C82.69^^107^1487^57
 ;;^UTILITY(U,$J,358.3,37077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37077,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37077,1,4,0)
 ;;=4^C82.69
 ;;^UTILITY(U,$J,358.3,37077,2)
 ;;=^5001530
 ;;^UTILITY(U,$J,358.3,37078,0)
 ;;=C82.60^^107^1487^58
 ;;^UTILITY(U,$J,358.3,37078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37078,1,3,0)
 ;;=3^Cutaneous Follicle Center Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,37078,1,4,0)
 ;;=4^C82.60
 ;;^UTILITY(U,$J,358.3,37078,2)
 ;;=^5001521
 ;;^UTILITY(U,$J,358.3,37079,0)
 ;;=D56.2^^107^1487^59
 ;;^UTILITY(U,$J,358.3,37079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37079,1,3,0)
 ;;=3^Delta-Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,37079,1,4,0)
 ;;=4^D56.2
 ;;^UTILITY(U,$J,358.3,37079,2)
 ;;=^340496
 ;;^UTILITY(U,$J,358.3,37080,0)
 ;;=D75.9^^107^1487^60
 ;;^UTILITY(U,$J,358.3,37080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37080,1,3,0)
 ;;=3^Disease of Blood/Blood-Forming Organs,Unspec
 ;;^UTILITY(U,$J,358.3,37080,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,37080,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,37081,0)
 ;;=D59.0^^107^1487^63
 ;;^UTILITY(U,$J,358.3,37081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37081,1,3,0)
 ;;=3^Drug-Induced Autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,37081,1,4,0)
 ;;=4^D59.0
 ;;^UTILITY(U,$J,358.3,37081,2)
 ;;=^5002323
 ;;^UTILITY(U,$J,358.3,37082,0)
 ;;=D59.2^^107^1487^64
 ;;^UTILITY(U,$J,358.3,37082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37082,1,3,0)
 ;;=3^Drug-Induced Nonautoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,37082,1,4,0)
 ;;=4^D59.2
 ;;^UTILITY(U,$J,358.3,37082,2)
 ;;=^5002325
 ;;^UTILITY(U,$J,358.3,37083,0)
 ;;=R59.9^^107^1487^67
 ;;^UTILITY(U,$J,358.3,37083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37083,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,37083,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,37083,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,37084,0)
 ;;=D47.3^^107^1487^68
 ;;^UTILITY(U,$J,358.3,37084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37084,1,3,0)
 ;;=3^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,37084,1,4,0)
 ;;=4^D47.3
 ;;^UTILITY(U,$J,358.3,37084,2)
 ;;=^5002258
 ;;^UTILITY(U,$J,358.3,37085,0)
 ;;=C82.09^^107^1487^69
 ;;^UTILITY(U,$J,358.3,37085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37085,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37085,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,37085,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,37086,0)
 ;;=C82.00^^107^1487^70
 ;;^UTILITY(U,$J,358.3,37086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37086,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,37086,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,37086,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,37087,0)
 ;;=C82.19^^107^1487^71
 ;;^UTILITY(U,$J,358.3,37087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37087,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37087,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,37087,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,37088,0)
 ;;=C82.10^^107^1487^72
 ;;^UTILITY(U,$J,358.3,37088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37088,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,37088,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,37088,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,37089,0)
 ;;=C82.29^^107^1487^73
 ;;^UTILITY(U,$J,358.3,37089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37089,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37089,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,37089,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,37090,0)
 ;;=C82.20^^107^1487^74
 ;;^UTILITY(U,$J,358.3,37090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37090,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Unspec Site
 ;;^UTILITY(U,$J,358.3,37090,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,37090,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,37091,0)
 ;;=C82.39^^107^1487^75
 ;;^UTILITY(U,$J,358.3,37091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37091,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37091,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,37091,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,37092,0)
 ;;=C82.30^^107^1487^76
 ;;^UTILITY(U,$J,358.3,37092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37092,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
 ;;^UTILITY(U,$J,358.3,37092,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,37092,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,37093,0)
 ;;=C82.49^^107^1487^77
 ;;^UTILITY(U,$J,358.3,37093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37093,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37093,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,37093,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,37094,0)
 ;;=C82.40^^107^1487^78
 ;;^UTILITY(U,$J,358.3,37094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37094,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,37094,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,37094,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,37095,0)
 ;;=C82.99^^107^1487^79
 ;;^UTILITY(U,$J,358.3,37095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37095,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37095,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,37095,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,37096,0)
 ;;=C82.90^^107^1487^80
 ;;^UTILITY(U,$J,358.3,37096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37096,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,37096,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,37096,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,37097,0)
 ;;=R59.1^^107^1487^65
 ;;^UTILITY(U,$J,358.3,37097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37097,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
 ;;^UTILITY(U,$J,358.3,37097,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,37097,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,37098,0)
 ;;=C91.40^^107^1487^84
 ;;^UTILITY(U,$J,358.3,37098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37098,1,3,0)
 ;;=3^Hairy Cell Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,37098,1,4,0)
 ;;=4^C91.40
 ;;^UTILITY(U,$J,358.3,37098,2)
 ;;=^5001771
 ;;^UTILITY(U,$J,358.3,37099,0)
 ;;=C91.42^^107^1487^82
 ;;^UTILITY(U,$J,358.3,37099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37099,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,37099,1,4,0)
 ;;=4^C91.42
 ;;^UTILITY(U,$J,358.3,37099,2)
 ;;=^5001773
 ;;^UTILITY(U,$J,358.3,37100,0)
 ;;=C91.41^^107^1487^83
 ;;^UTILITY(U,$J,358.3,37100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37100,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,37100,1,4,0)
 ;;=4^C91.41
 ;;^UTILITY(U,$J,358.3,37100,2)
 ;;=^5001772
 ;;^UTILITY(U,$J,358.3,37101,0)
 ;;=D57.01^^107^1487^85
 ;;^UTILITY(U,$J,358.3,37101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37101,1,3,0)
 ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
 ;;^UTILITY(U,$J,358.3,37101,1,4,0)
 ;;=4^D57.01
 ;;^UTILITY(U,$J,358.3,37101,2)
 ;;=^5002307
 ;;^UTILITY(U,$J,358.3,37102,0)
 ;;=D57.00^^107^1487^86
 ;;^UTILITY(U,$J,358.3,37102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37102,1,3,0)
 ;;=3^Hb-SS Disease w/ Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,37102,1,4,0)
 ;;=4^D57.00
 ;;^UTILITY(U,$J,358.3,37102,2)
 ;;=^5002306
 ;;^UTILITY(U,$J,358.3,37103,0)
 ;;=D57.02^^107^1487^87
 ;;^UTILITY(U,$J,358.3,37103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37103,1,3,0)
 ;;=3^Hb-SS Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,37103,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,37103,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,37104,0)
 ;;=D68.32^^107^1487^89
 ;;^UTILITY(U,$J,358.3,37104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37104,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,37104,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,37104,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,37105,0)
 ;;=C22.2^^107^1487^90
 ;;^UTILITY(U,$J,358.3,37105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37105,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,37105,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,37105,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,37106,0)
 ;;=D58.9^^107^1487^92
 ;;^UTILITY(U,$J,358.3,37106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37106,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,37106,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,37106,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,37107,0)
 ;;=C81.99^^107^1487^93
 ;;^UTILITY(U,$J,358.3,37107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37107,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37107,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,37107,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,37108,0)
 ;;=C81.90^^107^1487^94
 ;;^UTILITY(U,$J,358.3,37108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37108,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,37108,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,37108,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,37109,0)
 ;;=D89.2^^107^1487^95
 ;;^UTILITY(U,$J,358.3,37109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37109,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,37109,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,37109,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,37110,0)
 ;;=D05.12^^107^1487^98
 ;;^UTILITY(U,$J,358.3,37110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37110,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,37110,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,37110,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,37111,0)
 ;;=D05.11^^107^1487^99
 ;;^UTILITY(U,$J,358.3,37111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37111,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,37111,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,37111,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,37112,0)
 ;;=D05.10^^107^1487^100
 ;;^UTILITY(U,$J,358.3,37112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37112,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,37112,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,37112,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,37113,0)
 ;;=D50.0^^107^1487^101
 ;;^UTILITY(U,$J,358.3,37113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37113,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,37113,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,37113,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,37114,0)
 ;;=D50.9^^107^1487^102
 ;;^UTILITY(U,$J,358.3,37114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37114,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,37114,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,37114,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,37115,0)
 ;;=C46.9^^107^1487^103
 ;;^UTILITY(U,$J,358.3,37115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37115,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,37115,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,37115,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,37116,0)
 ;;=C22.0^^107^1487^104
 ;;^UTILITY(U,$J,358.3,37116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37116,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,37116,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,37116,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,37117,0)
 ;;=D05.02^^107^1487^105
 ;;^UTILITY(U,$J,358.3,37117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37117,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,37117,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,37117,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,37118,0)
 ;;=D05.01^^107^1487^106
 ;;^UTILITY(U,$J,358.3,37118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37118,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,37118,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,37118,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,37119,0)
 ;;=D05.00^^107^1487^107
 ;;^UTILITY(U,$J,358.3,37119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37119,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,37119,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,37119,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,37120,0)
 ;;=R59.0^^107^1487^66
 ;;^UTILITY(U,$J,358.3,37120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37120,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,37120,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,37120,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,37121,0)
 ;;=C83.59^^107^1487^108
 ;;^UTILITY(U,$J,358.3,37121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37121,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,37121,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,37121,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,37122,0)
 ;;=C83.50^^107^1487^109
 ;;^UTILITY(U,$J,358.3,37122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37122,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,37122,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,37122,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,37123,0)
 ;;=C43.9^^107^1487^112
 ;;^UTILITY(U,$J,358.3,37123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37123,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec Site
 ;;^UTILITY(U,$J,358.3,37123,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,37123,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,37124,0)
 ;;=C31.9^^107^1487^113
 ;;^UTILITY(U,$J,358.3,37124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37124,1,3,0)
 ;;=3^Malig Neop Accessory Sinus,Unspec
 ;;^UTILITY(U,$J,358.3,37124,1,4,0)
 ;;=4^C31.9
 ;;^UTILITY(U,$J,358.3,37124,2)
 ;;=^5000953
 ;;^UTILITY(U,$J,358.3,37125,0)
 ;;=C24.1^^107^1487^115
 ;;^UTILITY(U,$J,358.3,37125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37125,1,3,0)
 ;;=3^Malig Neop Ampulla of Vater
 ;;^UTILITY(U,$J,358.3,37125,1,4,0)
 ;;=4^C24.1
 ;;^UTILITY(U,$J,358.3,37125,2)
 ;;=^267100
 ;;^UTILITY(U,$J,358.3,37126,0)
 ;;=C21.0^^107^1487^116
 ;;^UTILITY(U,$J,358.3,37126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37126,1,3,0)
 ;;=3^Malig Neop Anus,Unspec
 ;;^UTILITY(U,$J,358.3,37126,1,4,0)
 ;;=4^C21.0
 ;;^UTILITY(U,$J,358.3,37126,2)
 ;;=^5000930
 ;;^UTILITY(U,$J,358.3,37127,0)
 ;;=C67.9^^107^1487^119
 ;;^UTILITY(U,$J,358.3,37127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37127,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,37127,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,37127,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,37128,0)
 ;;=C71.9^^107^1487^123
 ;;^UTILITY(U,$J,358.3,37128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37128,1,3,0)
 ;;=3^Malig Neop Brain,Unspec
 ;;^UTILITY(U,$J,358.3,37128,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,37128,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,37129,0)
 ;;=C18.9^^107^1487^125
 ;;^UTILITY(U,$J,358.3,37129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37129,1,3,0)
 ;;=3^Malig Neop Colon,Unspec
 ;;^UTILITY(U,$J,358.3,37129,1,4,0)
 ;;=4^C18.9
 ;;^UTILITY(U,$J,358.3,37129,2)
 ;;=^5000929
 ;;^UTILITY(U,$J,358.3,37130,0)
 ;;=C49.9^^107^1487^126
 ;;^UTILITY(U,$J,358.3,37130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37130,1,3,0)
 ;;=3^Malig Neop Connective/Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,37130,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,37130,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,37131,0)
 ;;=C62.12^^107^1487^127
 ;;^UTILITY(U,$J,358.3,37131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37131,1,3,0)
 ;;=3^Malig Neop Descended Left Testis
 ;;^UTILITY(U,$J,358.3,37131,1,4,0)
 ;;=4^C62.12
 ;;^UTILITY(U,$J,358.3,37131,2)
 ;;=^5001235
